Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: A review of their methodologies and results
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 64, Issue 1, Pages 21-32
Publisher
Wiley
Online
2011-09-01
DOI
10.1002/art.30653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
- (2010) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
- (2010) Johan Askling et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register
- (2010) W. G. Dixon et al. ARTHRITIS CARE & RESEARCH
- Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
- (2010) Anja Strangfeld et al. ARTHRITIS RESEARCH & THERAPY
- Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study
- (2009) K. Hellgren et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry
- (2009) X Mariette et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
- (2009) G R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
- (2009) D E Furst et al. ANNALS OF THE RHEUMATIC DISEASES
- Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?
- (2009) Johan Askling et al. ARTHRITIS AND RHEUMATISM
- Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry
- (2009) Francesca Bobbio Pallavicini et al. AUTOIMMUNITY REVIEWS
- Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials
- (2008) T Bongartz et al. ANNALS OF THE RHEUMATIC DISEASES
- The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
- (2008) J P Leombruno et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
- (2008) J Askling et al. ANNALS OF THE RHEUMATIC DISEASES
- Hematologic Malignant Neoplasms After Drug Exposure in Rheumatoid Arthritis
- (2008) Sasha Bernatsky ARCHIVES OF INTERNAL MEDICINE
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
- (2008) Allison L Smitten et al. ARTHRITIS RESEARCH & THERAPY
- Lung cancer after exposure to disease modifying anti-rheumatic drugs
- (2007) Sasha Bernatsky et al. LUNG CANCER
- Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population
- (2007) Lydia Abásolo et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started